BioPharmSignal logoBioPharmSignal

Biotech News

Sanofi: Information concerning the total number of voting rights and shares – September 2026

Sanofi (SNY)SanofiCommercial

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

Related news

SNYSanofi2026-09-11 16:30 EST

Sanofi: Information concerning the total number of voting rights and shares - August 2026

SNDXSyndax Pharmaceuticals2026-09-01 11:00 EST

Syndax Announces Participation in September Investor Conferences

SNYSanofi2026-10-12 16:05 EST

Sanofi: Informations relatives au nombre de droits de vote et d'actions – Septembre 2026

REPLReplimune Group2026-10-01 20:01 EST

Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma

SNDXSyndax Pharmaceuticals2026-10-15 20:01 EST

Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List

KURAKura Oncology2026-09-08 11:00 EST

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

ANIPANI Pharmaceuticals2026-10-19 10:55 EST

ANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsules

KURAKura Oncology2026-10-07 11:15 EST

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

View all latest news

Sanofi

Sanofi is a global healthcare company with meaningful exposure to immunology, vaccines, rare disease, and consumer health. The company has been building a more focused innovation story while maintaining a broad global base.

Recent company news

SNYSanofi2026-10-12 16:05 EST

Sanofi: Informations relatives au nombre de droits de vote et d'actions – Septembre 2026

SNYSanofi2026-10-12 16:05 EST

Sanofi: Information concerning the total number of voting rights and shares – September 2026

SNYSanofi2026-10-06 05:30 EST

Communiqué de presse : Mise en ligne du document «Q3 2026 aide-mémoire »

SNYSanofi2026-10-06 05:30 EST

Press Release : Availability of the aide-mémoire for Q3 2026 results

SNYSanofi2026-10-01 05:00 EST

Communiqué de presse : Sanofi et Regeneron élargissent leur Alliance mondiale avec plusieurs anticorps immunologiques de nouvelle génération à action prolongée

Stock data

Close
40.97 USD
Market cap
102.45B USD
Exchange
NASDAQ
Sector
Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
Location
United States